Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
adrenomyeloneuropathy
adverse drug reaction
axonal degeneration
axonal spheroid
CAT scan, emission
complications
demyelinating disease
disability rating scale, neurological
disability, neurological
encephalitis
encephalitis, human immunodeficiency virus type 1
epidemiology of neurology
gadolinium
gammaglobulin therapy, intravenous
highly active antiretroviral therapy
human immunodeficiency virus type 1
leukoencephalopathy
monoclonal antibodies
MRI
MRI, abnormal
MRI, black holes on
MRI, contrast enhanced
MRI, contrast enhanced, high dose
MRI, contrast enhanced, triple dose
MRI, demyelinating disease
MRI, diffusion tensor
MRI, diffusion weighted
MRI, magnetization transfer sequence
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRI, spinal cord
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, diagnosis of
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, relapsing
multiple sclerosis, spinal form
multiple sclerosis, treatment of
natalizumab
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS-multiple
neoplasm, metastatic to CNS-treatment of
neoplasm, primary intracerebral
neoplasm, primary of CNS
neurologic disease, diagnoses of
prognosis
progressive multifocal leucoencephalopathy
radiation therapy, stereotactic
review article
single photon emission computed tomography
single photon emission computed tomography, thallium
spinal cord
spinal cord, lesion of
symmetric brain lesions
treatment of neurologic disorder
white matter disease
white matter, dirty-appearing
Showing articles 2850 to 2900 of 6953 << Previous Next >>

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Gray and White Matter Brain Atrophy and Neuropsychological Impairment in Multiple Sclerosis
Neurol 66:685-692, Sanfilipo,M.P.,et al, 2006

Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006

Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006

Episodic Neurologic Dysfunction with Migraine and Reversible Imaging Findings After RadiationRRH
Neurol 67:676-678, Pruitt,A.,et al, 2006

Neonatal MRI to Predict Neurodevelopmental Outcomes in Preterm Infants
NEJM 355:685-694,727, Woodward,L.J.,et al, 2006

Fragile X Premutation With Atypical Symptoms at Onset
Arch Neurol 63:1135-1138, Cellini,E.,et al, 2006

Spinal Cord Ischemia: Clinical and Imaging Patterns, Pathogenesis, and Outcomes in 27 Patients
Arch Neurol 63:1113-1120, Novy,J.,et al, 2006

Multiple Reversible MR Signal Changes Caused by Epstein-Barr Virus Encephalitis
AJNR 27:1447-1449, Hagemann,G.,et al, 2006

Creutzfeldt-Jakob Disease: Comparative Analysis of MR Imaging Sequences
AJNR 27:1459-1462, Kallenberg,K.,et al, 2006

Restless Legs Syndrome: Is Treatable But Under-Recognised
BMJ 333:457-458, Medcalf,P. &Bhatia,K.P., 2006

Reversible Delayed Posthypoxic Leukoencephalopathy
AJNR 27:1763-1765, MolloyS.,et al, 2006

Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy
AJNR 27:1612-1616, Hill,M.E.,et al, 2006

CT Arteriography and Venography in Pulsatile Tinnitus: Preliminary Results
AJNR 27:1635-1638, Krishnan,A.,et al, 2006

Magnetic Resonance Imaging of the Fetal Brain and Spine: An Increasingly Important Tool in Prenatal Diagnosis, Part 1
AJNR 27:1604-1611, Glenn,O.A. &Barkovich,A.J., 2006

Does High-Field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis
AJNR 27:1794-1798, Wattjes,M.P.,et al, 2006

Do Transient Ischemic Attacks with Diffusion-Weighted Imaging Abnormalities Correspond to Brain Infarctions?
AJNR 27:1782-1787, Oppenheim,C.,et al, 2006

Reversible Reduction of Apparent Diffusion Coefficient Values in Bilateral Internal Capsules in Transient Hypoglycemia-Induced Hemiparesis
AJNR 27:1760-1762, Albayram,S.,et al, 2006

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006

West Nile Virus Neuroinvasive Disease
Ann Neurol 60:286-300, Davis,L.E.,et al, 2006

Baseline MRI Predicts Future Attacks and Disability in Clinically Isolated Syndromes
Neurol 67:968-972, Tintore,M.,et al, 2006

Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke
Stroke 37:2463-2466, Neumann-Haefelin,T.,et al, 2006

Vertebral Artery Dissection, Presenting Findings and Predictors of Outcome
Stroke 37:2499-2503, Arnold,M.,et al, 2006

Leukoencephalopathy Induced by Levamisole Alone for the Treatment of Recurrent Aphthous Ulcers
Neurol 67:1065-1067, Liu,J.M.,et al, 2006

The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006

Clinical and MRI Correlates of Cerebral Palsy, The European Cerebral Palsy Study
JAMA 296:1602-1608,1684, Bax,M.,et al, 2006

The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke
Stroke 37:2957-2962,2865, Kent,D.M.,et al, 2006

Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?
Stroke 37:2963-2969, Kent,D.M.,et al, 2006

Is Penumbral Imaging Useful for Extending the Treatment Window for Intravenous Tissue Plasminogen Activator?
Ann Neurol 60:499-501, Fisher,M., 2006

Prediction of Thrombolytic Efficacy in Acute Ischemic Stroke Using Thin-Section Noncontrast CT
Neurol 67:1846-1848, Kim,E.Y.,et al, 2006

In Vivo Detection of Cortical Plaques by MR Imaging in Patients with Multiple Sclerosis
AJNR 27:2161-2167, Bagnato,F.,et al, 2006

Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
AJNR 27:2179-2190, Bartynski,W.S.,et al, 2006

Case 35-2006: A Newborn Boy with Hypotonia
NEJM 355:2132-2142, Brown,R.H.,et al, 2006

New Concepts in Surgery of WHO Grade II Gliomas: Functional Brain Mapping, Connectionism and Plasticity--A Review
J Neurooncol 79:77-115, Duffau,H., 2006

Pathologic Laughing and Intractable Hiccups Can Occur Early in Multiple Sclerosis
Neurol 67:1684-1686, de Seze,J.,et al, 2006

Practice Parameter: Diagnostic Assessment of the Child with Status Epilepticus (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the practice Committee of the Child Neurology Society
Neurol 67:1542-1550, Riviello,J.J. Jr.,et al, 2006

Rosai-Dorfman Disease Presenting with Widespread Intracranial and Spinal Cord Involvement
Neurol 67:1551-1555, Kidd,D.P.,et al, 2006

Spinal Epidural Abscess
NEJM 355:2012-2020, Darouiche,R.O., 2006

Cerebral Venous Thrombosis, A Review
The Neurologist 12:32-38, Ehtisham,A. &Stern,B.J., 2006

Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006

Epilepsy in Children
Lancet 367:499-524, Guerrini,R., 2006

The First Seizure and Its Management in Adults and Children
BMJ 332:339-342, Pohlmann-Eden,B.,et al, 2006

Vasculopathic Changes in the Cerebral Arterial System with Neurobrucellosis
AJNR 27:384-386, Adaletli,I.,et al, 2006

Standardized MR Imaging Protocol for Multiple Sclerosis:Consortium of MS Centers Consensus Guidelines
AJNR 27:455-461, Simon,J.H.,et al, 2006

Remote Cerebellar Hemorrhage
AJNR 27:387-390, Amini,A.,et al, 2006

CT and MR Imaging Findings in Methanol Intoxication
AJNR 27:452-454, Blanco,M.,et al, 2006

Diffusion MR Imaging in a Case of Acute Ischemic Optic Neuropathy
AJNR 27:255-257, Al-Shafai,L.S.&Mikulis,D.J., 2006

Hyperostosis Frontalis Interna
Arch Neurol 63:291, Waclawik,A.J., 2006

The "Eye-of-the-Tiger" Sign is Not Pathognomonic of the PANK2 Mutation
Arch Neurol 63:292-293, Kumar,N.,et al, 2006



Showing articles 2850 to 2900 of 6953 << Previous Next >>